- February 25, 2019
Inhibits adhesion and aggregation of blood platelets (thrombocytes) and thus prevents blood clots (thrombi) in developing countries (inhibition of platelet aggregation) .Rompirin 100mg is used to reduce the risk of mortality in patients with suspected heart attack myocardial infarction, to reduce the risk of morbidity and mortality in patients with myocardial infarction in history for secondary prevention of stroke, reducing the risk of transient ischemic attacks (TIAs) and stroke in patients with TIA to reduce the risk to patients with stable and unstable angina, thromboembolism prophylaxis after surgery or vascular surgery, carotid endarterectomy, arteriovenous shunts, for the prophylaxis of deep vein thrombosis and pulmonary embolism after long-term immobilization, ex. after major surgery to reduce the risk of myocardial infarction primary people with cardiovascular risk factors, eg. diabetes, hyperlipidemia, hypertension, obesity, smoking, advanced age for the prophylact
